(OVV) Ovintiv - Overview
Sector: Energy | Industry: Oil & Gas E&P | Exchange: NYSE (USA) | Market Cap: 16.507m USD | Total Return: 57.5% in 12m
Avg Turnover: 233M
EPS Trend: -28.1%
Qual. Beats: 2
Rev. Trend: -95.7%
Qual. Beats: 0
Warnings
Altman Z'' 0.26 < 1.0 - financial distress zone
Below Avwap Earnings
Tailwinds
No distinct edge detected
Ovintiv Inc. is a North American energy company focused on the exploration, development, and marketing of crude oil, natural gas liquids, and natural gas. The firm maintains a multi-basin portfolio with core operations in the Permian and Anadarko basins in the United States, alongside significant assets in the Montney formation across Alberta and British Columbia.
Operating within the Exploration and Production (E&P) sector, the company utilizes a business model centered on unconventional resource development, specifically horizontal drilling and multi-well pad completion. This sector is characterized by high capital intensity and sensitivity to global commodity price fluctuations, requiring efficient cost structures to maintain margins during market volatility.
To gain deeper insights into the companys financial health and valuation metrics, consider reviewing the detailed analytics available on ValueRay.
Formerly known as Encana Corporation, the company rebranded to Ovintiv Inc. in 2020 following its redomiciliation from Canada to the United States. It is headquartered in Denver, Colorado, and manages its activities through distinct USA and Canadian operational segments.
- Permian Basin production growth drives total oil and liquids revenue expansion
- Natural gas price volatility impacts cash flow from Montney and Anadarko assets
- Capital expenditure efficiency in shale drilling determines free cash flow yields
- Regional pipeline capacity constraints influence realized pricing differentials in Western Canada
- Debt reduction progress and shareholder buyback programs influence equity valuation multiples
| Net Income: 771.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 8.92 > 1.0 |
| NWC/Revenue: -15.65% < 20% (prev -19.77%; Δ 4.12% < -1%) |
| CFO/TA 0.17 > 3% & CFO 3.81b > Net Income 771.0m |
| Net Debt (9.08b) to EBITDA (2.73b): 3.33 < 3 |
| Current Ratio: 0.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (268.2m) vs 12m ago 3.00% < -2% |
| Gross Margin: 47.04% > 18% (prev 0.55%; Δ 4.65k% > 0.5%) |
| Asset Turnover: 42.67% > 50% (prev 46.79%; Δ -4.11% > 0%) |
| Interest Coverage Ratio: 1.36 > 6 (EBITDA TTM 2.73b / Interest Expense TTM 381.0m) |
| A: -0.06 (Total Current Assets 1.81b - Total Current Liabilities 3.21b) / Total Assets 22.3b |
| B: 0.08 (Retained Earnings 1.73b / Total Assets 22.3b) |
| C: 0.02 (EBIT TTM 517.0m / Avg Total Assets 21.0b) |
| D: 0.24 (Book Value of Equity 2.61b / Total Liabilities 10.7b) |
| Altman-Z'' = 0.26 = B |
| DSRI: 1.20 (Receivables 1.48b/1.26b, Revenue 8.94b/9.18b) |
| GMI: 1.17 (GM 47.04% / 55.17%) |
| AQI: 1.00 (AQ_t 0.20 / AQ_t-1 0.20) |
| SGI: 0.97 (Revenue 8.94b / 9.18b) |
| TATA: -0.14 (NI 771.0m - CFO 3.81b) / TA 22.3b) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of May 29, 2026, the stock is trading at USD 55.81 with a total of 3,535,357 shares traded.
Over the past week, the price has changed by -6.25%,
over one month by -4.53%,
over three months by +10.92% and
over the past year by +57.48%.
Ovintiv has received a consensus analysts rating of 4.26. Therefore, it is recommended to buy OVV.
- StrongBuy: 11
- Buy: 7
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 70.3 | 25.9% |
P/E Trailing = 19.3224
P/E Forward = 8.6356
P/S = 1.862
P/B = 1.4282
P/EG = 1.8514
Revenue TTM = 8.94b USD
EBIT TTM = 517.0m USD
EBITDA TTM = 2.73b USD
Long Term Debt = 5.52b USD (from longTermDebt, last quarter)
Short Term Debt = 1.01b USD (from shortTermDebt, last quarter)
Debt = 9.11b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.41b
Net Debt = 9.08b USD (calculated: Debt 9.11b - CCE 26.0m)
Enterprise Value = 25.6b USD (16.5b + Debt 9.11b - CCE 26.0m)
Interest Coverage Ratio = 1.36 (Ebit TTM 517.0m / Interest Expense TTM 381.0m)
EV/FCF = 6.71x (Enterprise Value 25.6b / FCF TTM 3.82b)
FCF Yield = 14.91% (FCF TTM 3.82b / Enterprise Value 25.6b)
FCF Margin = 42.66% (FCF TTM 3.82b / Revenue TTM 8.94b)
Net Margin = 8.62% (Net Income TTM 771.0m / Revenue TTM 8.94b)
Gross Margin = 47.04% ((Revenue TTM 8.94b - Cost of Revenue TTM 4.74b) / Revenue TTM)
Gross Margin QoQ = 55.73% (prev 26.45%)
Tobins Q-Ratio = 1.15 (Enterprise Value 25.6b / Total Assets 22.3b)
Interest Expense / Debt = 4.18% (Interest Expense 381.0m / Debt 9.11b)
Taxrate = 21.0% (US default 21%)
NOPAT = 408.4m (EBIT 517.0m * (1 - 21.00%))
Current Ratio = 0.56 (Total Current Assets 1.81b / Total Current Liabilities 3.21b)
Debt / Equity = 0.79 (Debt 9.11b / totalStockholderEquity, last quarter 11.6b)
Debt / EBITDA = 3.33 (Net Debt 9.08b / EBITDA 2.73b)
Debt / FCF = 2.38 (Net Debt 9.08b / FCF TTM 3.82b)
Total Stockholder Equity = 10.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.68% (Net Income 771.0m / Total Assets 22.3b)
RoE = 7.11% (Net Income TTM 771.0m / Total Stockholder Equity 10.8b)
RoCE = 3.16% (EBIT 517.0m / Capital Employed (Equity 10.8b + L.T.Debt 5.52b))
RoIC = 2.04% (NOPAT 408.4m / Invested Capital 20.1b)
WACC = 7.06% (E(16.5b)/V(25.6b) * Re(9.14%) + D(9.11b)/V(25.6b) * Rd(4.18%) * (1-Tc(0.21)))
Discount Rate = 9.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -50.60 | Cagr: -1.30%
[DCF] Terminal Value 77.97% ; FCFF base≈2.93b ; Y1≈3.36b ; Y5≈4.95b
[DCF] Fair Price = 232.5 (EV 74.4b - Net Debt 9.08b = Equity 65.3b / Shares 281.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -28.05 | EPS CAGR: -4.52% | SUE: 2.59 | # QB: 2
Revenue Correlation: -95.69 | Revenue CAGR: -10.19% | SUE: 0.09 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.06 | Chg30d=-3.97% | Revisions=-20% | Analysts=18
EPS next Quarter (2026-09-30): EPS=2.02 | Chg30d=-0.27% | Revisions=-29% | Analysts=17
EPS current Year (2026-12-31): EPS=7.80 | Chg30d=-3.85% | Revisions=+33% | GrowthEPS=+61.2% | GrowthRev=+9.3%
EPS next Year (2027-12-31): EPS=7.75 | Chg30d=-0.91% | Revisions=+5% | GrowthEPS=-0.6% | GrowthRev=-4.7%
[Analyst] Revisions Ratio: +33%